Introduction:
The global pandemic caused by a novel coronavirus, termed “severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2)”, emerged in Hubei
province in China in December 2019. Follow on to this, the first
official announcement of a diagnosed patient with coronavirus disease
2019 (COVID-19) in Iran was made on February 19, 2020. (1). As of June
26, a total of 2 020 217 724 diagnosed patients had been confirmed via
laboratory assessments, and 177 852 patients had recovered or had been
discharged from hospitals. This surely stretched thin the provision of
healthcare on different healthcare sectors including cardiovascular
surgery. The impact of this is still evolving despite resuming limited
capacity to provide service to our cohort at large. The actual
after-math from this has not been concluded. Hence, in this review we
will reflect on the restructuring the pandemic virus has afflicted and
its virulence on multilayered in our healthcare system.